Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice (Q34225457)

31 July 2017

Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice (English)

1 reference

31 July 2017

Michael F O'Neill

1

1 reference

31 July 2017

Claire Heron-Maxwell

2

1 reference

31 July 2017

Michael W Conway

3

1 reference

31 July 2017

James A Monn

4

1 reference

31 July 2017

Paul Ornstein

5

1 reference

31 July 2017

1 October 2003

1 reference

31 July 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

31 July 2017

45

1 reference

31 July 2017

565-574

1 reference

31 July 2017

5

1 reference

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

5-HT2 receptor subtypes: a family re-united?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Novel potent selective phenylglycine antagonists of metabotropic glutamate receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

DCG-IV inhibits synaptic transmission by activation of NMDA receptors in area CA1 of rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Contribution of social factors to opiate-induced activation in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Agonists of cyclic AMP-coupled metabotropic glutamate receptors in adult rat cortical slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Metabotropic glutamate receptors: novel targets for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Neurotoxicity of (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Sequence and expression of a metabotropic glutamate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxioly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Effects of the group II metabotropic glutamate receptor agonist, LY354740 on schedule-controlled behaviour in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

The metabotropic glutamate receptors: structure and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That Is Mediated by Striatal Dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

The role of 5-HT2A receptors in antipsychotic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Metabotropic glutamate receptors in brain function and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Dopamine receptors and the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Metabotropic glutamate group II receptors are responsible for the depression of synaptic transmission induced by ACPD in the dentate gyrus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

Distribution and ontogeny of 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid-sensitive and quisqualate-insensitive [3H]glutamate binding sites in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900232-6

10.1016/S0028-3908(03)00232-6

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference